Trademark Overview
On Wednesday, March 4, 2026, a trademark application was filed for NUCORE with the United States Patent and Trademark Office. The USPTO has given the NUCORE trademark a serial number of 99683086. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, March 4, 2026. This trademark is owned by Nucore Health, PLLC. The NUCORE trademark is filed in the Pharmaceutical Products category with the following description:
Drug delivery agents in the form of tablets, capsules, powders, dissolvable fi lms,suppositories, and injectables/injections, and coatings that facilitate the delivery of pharmaceutical preparations; Hormone replacement therapy preparations; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Dietary and nutritional supplements; Synthetic peptides for the treatment of viral,
metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual
dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal,
hormonal, dermatological, psychiatric and immune system related disorders and to restore energy,
improve cognitive function, enhance sexual health, build muscle, and optimize metabolism for overall
vitality and weight loss
